Clinical trial
HIV Vaccine Trial in Thai Adults
NCT00223080 · U.S. Army Medical Research and Development Command, U.S. Fed · Completed
Key facts
| NCT number | NCT00223080 |
|---|---|
| Title | HIV Vaccine Trial in Thai Adults |
| Official title | A Phase III Trial of Aventis Pasteur Live Recombinant ALVAC-HIV (vCP1521) Priming With VaxGen gp120 B/E (AIDSVAX B/E) Boosting in HIV-uninfected Thai Adults |
| Lead sponsor | U.S. Army Medical Research and Development Command, U.S. Fed |
| Collaborators | United States Army Medical Materiel Development Activity U.S. Fed Armed Forces Research Institute of Medical Sciences, Thailand Walter Reed Army Institute of Research (WRAIR) MCM Vaccines B.V… |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Biological, Other |
| Interventions | ALVAC-HIV vCP1521 + AIDSVAX, ALVAC Placebo + AIDSVAX Placebo |
| Enrollment | 16,402 |
| Start date | Oct 1, 2003 |
| Primary completion | Jul 1, 2006 |
| Completion | Jun 1, 2009 |
| First posted | Sep 22, 2005 |
| Last update posted | Apr 24, 2019 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: